News & Topics
News&Topics

2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008 / 2007 / 2006 / 2005

2014.12.24
Notice of Revision of the Long Range Plan: FY2014 to FY2016
2014.12.24
SymBio's Long Range Plan: FY2014 to FY2016 (Revised Version)
2014.12.01
Analyst Report: Shared Research initiates coverage on SymBio
2014.12.01
Completion of Payment for Subscription of the 2nd Unsecured Bonds with Convertible Bond Type Stock Acquisition Rights and the 34th Stock Acquisition Rights by Third-Party Allotment
2014.11.14
Notice of the Subscription for the 2nd Unsecured Bonds with Convertible Bond Type Stock Acquisition Rights and the 34th Stock Acquisition Rights by Third-Party Allotment
2014.11.13
Notice of Revision of the Financial Forecast for FY2014
2014.11.07
Notice Concerning Non-Operation Income
2014.11.07
Summary of Financial Results For the Third Quarter of Fiscal Year Ending December 31, 2014[Japanese GAAP](Non-consolidated)
2014.11.06
Completion of Patient Enrollment of TREAKISYM® Phase II Trial in Patient with Chronic Lymphocytic Leukemia (CLL)
2014.10.13
Analyst Report: Edison initiates coverage on SymBio
2014.09.19
Notice Concerning Change in Status of Major shareholder
2014.09.18
Notice Concerning Relocation of Head Office
2014.08.14
Onconova's Announcement in the Development of Rigosertib for patients with MDS in Second Quarter 2014
2014.08.06
Notice Concerning Non-Operation Expense
2014.08.06
Summary of Financial Results For the Second Quarter of Fiscal Year Ending December 31, 2014[Japanese GAAP](Non-consolidated)
2014.06.18
SymBio Announces Korea NDA Approval of Additional Indication for Bendamustine Hydrochloride (SyB L-0501)
2014.05.08
Notice Concerning Non-Operation Expense
2014.05.08
Summary of Financial Results For the First Quarter of Fiscal Year Ending December 31, 2014[Japanese GAAP](Non-consolidated)
2014.04.30
Notice Concerning Adjustment to Exercise Price of Stock Option
2014.04.30
Notice Concerning Finalized Details on Issuance of Stock Acquisition Rights (Stock Option) to the Company's Employees
2014.04.30
Notice Concerning Finalized Details on Issuance of Stock Acquisition Rights (Stock Option) to the Company's Directors
2014.04.15
Notice Concerning the Issuance of Stock Acquisition Rights as Stock Option to Employees
2014.04.15
Notice Concerning the Issuance of Stock Acquisition Rights as Stock Option to Directors
2014.03.28
Notice of Shareholder Voting Results for the 9th Ordinary General Meeting of Shareholders
2014.03.27
Notice Concerning the Appointment of Directors
2014.03.27
Announcement Personnel Changes
2014.03.06
Notice Concerning the Partial Amendment to the Articles of Incorporation and Election of Directors
2014.03.06
Notice Concerning the Issuance of Stock Acquisition Rights as Stock Option to Directors
2014.02.20
Onconova Announces Results from Phase 3 ONTIME Study of Rigosertib in Higher Risk Myelodysplastic Syndromes (MDS)
2014.02.20
SymBio's Long Range Plan: FY2014 to FY2016
2014.02.12
Summary of Financial Statements for the Fiscal Year Ended December 31, 2013[Japanese GAAP](Non-consolidated)